Skip to main content

IDWeek 2022 Main banner

Tweets by IDWeek 2022

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

481 Views

Poster Session: Adult Vaccines

112 - Interim Results From a Phase 2, Randomized, Observer-Blind, Placebo-Controlled, Dose-Finding Trial of an mRNA-Based Cytomegalovirus Vaccine in Healthy Adults

Thursday, October 20, 2022

12:15 PM – 1:30 PM US ET

Location: Hall B + C

The ePoster content is available to users who are logged in.<br><br>Please click the login button at the top right corner and then come back here to use this button.

Presenting Author(s)

Lori Panther, MD, MPH

Senior Director
Moderna, Inc.
Cambridge, Massachusetts, United States

Co-Author(s)

CF

Carlos Fierro, MD

Investigator
Johnson County Clin-Trials
Lenexa, Kansas, United States
DB

Daniel Brune, MD

Optimal Research
Peoria, Illinois, United States
RL

Richard Leggett, DO

Crossroads Clinical Research
Victoria, Texas, United States
JP

James Peterson, MD

Foothill Family Clinic
Salt Lake City, Utah, United States
PP

Paul Pickrell, MD

Tekton Research
Austin, Texas, United States
JL

Jiang Lin, PhD

Moderna, Inc.
Cambridge, Massachusetts, United States
KW

Kai Wu, PhD

Moderna, Inc.
Cambridge, Massachusetts, United States
HL

Heather Lee, BS

Director
Moderna, Inc.
Cambridge, Massachusetts, United States
RH

Roxane Hasselbeck, BA

Moderna, Inc.
Cambridge, Massachusetts, United States
AN

Andrew Natenshon, MA

Moderna, Inc.
Cambridge, Massachusetts, United States
JM

Jacqueline Miller, MD

Moderna, Inc.
Cambridge, Massachusetts, United States